• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Researchers identify molecule that promotes growth of RCC

Article

Mayo Clinic researchers say they have identified a molecule known as B7-H4 that blocks the immune system, thereby helping renal cell carcinoma grow and metastasize.

Mayo Clinic researchers say they have identified a molecule known as B7-H4 that blocks the immune system, thereby helping renal cell carcinoma grow and metastasize.

Researchers examined 250 fresh-frozen tumor specimens removed from patients with RCC, then sorted the tumors by those that showed B7-H4 and those that did not. When comparing clinical and laboratory data, a pattern emerged that associated active B7-H4 with fatal, metastatic cancers, compared with tumors lacking H7-B4.

Patients with RCC are three times as likely to die from cancer if their B7-H4 is active than those whose tumors do not express the molecule. Patients with RCC tumors expressing both B7-H4 and B7-H1, another member of the B7 family of molecules, pose an even greater risk of death than those with tumors that express one or the other alone.

The study appears in the Proceedings of the National Academy of Sciences (2006; 103:10391-6).

“Based on these findings, we conclude that B7-H4 has the potential to be a useful prognostic biomarker for patients with RCC,” said first author Amy Krambeck, MD, of the Mayo Clinic, Rochester, MN. “In addition, B7-H4 represents a new target to attack tumor cells as well as tumor vessels, thus improving treatment options for patients with RCC.”

Related Videos
Human kidney cross section on scientific background | © Crystal light - stock.adobe.com
Mature woman with her doctor | Image Credit: © pucko_ns - stock.adobe.com
Gary D. Steinberg, MD, an expert on bladder cancer
Jaleh Fallah, MD, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.